Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The majority of cases with frontotemporal dementia (FTD) have no tau deposition in the brain, yet mutations in the tau gene lead to a similar clinical phenotype with insoluble tau depositing in neuropathological lesions. We report two tau gene mutations at positions +19 and +29, in the intronic sequences immediately following the stem loop structure in exon 10, which segregate with FTD. Exon-trapping experiments showed that these gene mutations alter the splicing out of exon 10 and produce an increase in tau isoforms with three microtubule binding domains (three repeat tau). Mutagenesis experiments demonstrated that the +19 mutation was responsible for the increase in three repeat tau, possibly by altering an intron silencer modulator sequence element found at this region of the gene. Microtubule binding experiments revealed a significant decrease in microtubule assembly with increasing amounts of three and decreasing amounts of four repeat tau. Brain autopsy was available in one case. Analysis of the type of soluble tau isoforms revealed an increase in three repeat tau and an absence of tau isoforms with exon 3 inserts. No insoluble tau was isolated in the tissue fractions, consistent with the absence of tau-positive histopathology. There was also an increase in tau degradation products suggestive of increased proteolysis. This increase in tau breakdown products was associated with TUNEL- and activated caspase-3-positive neurons identified histologically. These studies show that increases in soluble three repeat tau can be responsible for FTD in cases with tau gene mutations in the intronic region immediately adjacent to the stem loop in exon 10. These cases of FTD have tau isoforms (without exon 3 inserts) that do not form abnormal aggregates and appear more prone to proteolysis. The increase in tau proteolysis was associated with increased evidence of apoptosis. This mechanism of neurodegeneration may be more applicable to the majority of FTD cases, which do not accumulate insoluble tau deposits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“Mutant tau alleles included the +19 and +29 mutants and the previously reported S305S and +16 mutations (Hutton et al., 1998; Stanford et al., 2000).”
BackgroundLee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480 · cited 7×
“All tau gene mutations producing splicing defects increase the levels of four repeat tau isoforms that accumulate as insoluble aggregates in the brain (BueÂe et al., 2000; Crowther and Goedert, 2000; Garcia and Cleveland, 2001; Lee et al., 2001).”
BackgroundInfluentialTauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939 · cited 1×
“This differs signi®cantly from current animal models where the transgenic expression of human tau causes increased intracellular tau and neurodegeneration without aggregate formation (Gotz, 2001; Wittmann et al., 2001).”
BackgroundGoedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929 · cited 2×
“The alternative splicing of exon 10 generates tau isoforms containing either three or four repeats of 31 or 32 amino acids (Goedert and Jakes, 1990).”
BackgroundMethodTau filament formation in transgenic mice expressing P301L tau
Götz, J., Chen, F., Barmettler, R., & Nitsch, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006531200 · Cited by 495 · cited 1×
“Transgenic mice expressing the P301L mutation have TUNEL-positive neurons in addition to those expressing phosphorylated tau (Gotz et al., 2001).”
BackgroundStanford, P. M., Halliday, G. M., Brooks, W. S., Kwok, J. B. J., Storey, C. E., Creasey, H., Morris, J. G. L., Fulham, M. J., & Schofield, P. R. (2000) · Brain · doi:10.1093/brain/123.5.880 · Cited by 262
Self-citationTau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis
Canu, N., Dus, L., Barbato, C., Ciotti, M. T., Brancolini, C., Rinaldi, A. M., Novak, M., Cattaneo, A., Bradbury, A., & Calissano, P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07061.1998 · Cited by 232 · cited 2×
“These data suggest that apoptosis is a mechanism of cell death in FTD. Tau is a substrate of the proteases calpain-1 and caspase-3 during apoptosis (Canu et al., 1998; Yen et al., 1999) and tau fragments generated during apoptosis act as effectors to further apoptosis generating a positive feedback…”
BackgroundFrequency of Tau Gene Mutations in Familial and Sporadic Cases of Non-Alzheimer Dementia
Poorkaj, P., Grossman, M., Steinbart, E., Payami, H., Sadovnick, A., Nochlin, D., Tabira, T., Trojanowski, J. Q., Borson, S., Galasko, D., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.383 · Cited by 171 · cited 5×
“E-mail: g.halliday@unsw.edu.au”
BackgroundInfluentialBaker, M., Kwok, J. B. J., Kucera, S., Crook, R., Farrer, M., Houlden, H., Isaacs, A., Lincoln, S., Onstead, L., Hardy, J., et al. (1997) · Annals of Neurology · doi:10.1002/ana.410420516 · Cited by 83 · cited 1×
“All exons of the tau gene (exons 1, 2, 3, 4, 4A, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14) were ampli®ed by polymerase chain reaction (PCR) from genomic DNA using primers derived from 5¢ and 3¢ intronic sequences (Baker et al., 1997).”
Method
Cited by
Gong, C.-X., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 644
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Alternative splicing in disease and therapy
Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L. (2004) · Nature Biotechnology · doi:10.1038/nbt964 · Cited by 527
Jiang, H., Mankodi, A., Swanson, M. S., Moxley, R. T., & Thornton, C. A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh327 · Cited by 526
Post-translational modifications of tau protein in Alzheimer’s disease
Gong, C.-X., Liu, F., Grundke-Iqbal, I., & Iqbal, K. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0221-0 · Cited by 437
“Each of the six tau isoforms possibly has its particular physiological roles and differential biological activities because they are differentially expressed during development and have different activity to stimulate microtubule assembly (Utton et al., 2001; Stanford et al., 2003).”
Metadata
- Authors
- Stanford, P. M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 126
- Issue
- 4
- Pages
- 814-826
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2115289458
- Cited by
- 125
- References
- 9
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.